NanoViricides

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-129
-133
-132
-161
EBITDA
-1,900
-2,087
-1,652
-1,934
EBIT
-2,030
-2,220
-1,785
-2,095
Net Income
-1,989
-2,220
-1,785
-2,095
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,930
-2,049
-1,678
-1,712
Cash
3,213,256,000
5,150,580,000
1,125
1,558
Basic Shares
21,609
19,850
17,082
16,511

Annual Financials

Values in thousands2025-06-302024-06-302023-06-302022-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-743
-759
-747
-723
EBITDA
-8,723
-7,485
-7,840
-7,378
EBIT
-9,466
-8,244
-8,587
-8,101
Net Income
-9,466
-8,294
-8,588
-8,106
Net Change In Cash
0
0
0
0
Free Cash Flow
-8,535
-6,472
-5,821
-6,215
Cash
1,558
4,797
8,149
14,066
Basic Shares
15,117
11,871
11,626
11,534

Earnings Calls

QuarterEPS
2026-03-31
-$0.09
2025-12-31
-$0.11
2025-09-30
-$0.10
2025-06-30
-$0.12